CARRIE ZIPPERER: Open Payments
NPI 1477784833 · COLUMBIA, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$728 in 37 payments from 13 companies in 2025. Trend: 2023 $1,038 · 2024 $888 · 2025 $728
Food & beverage: $728
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $196 |
| Novartis Pharmaceuticals Corporation | 3 | $75 |
| UCB, Inc. | 3 | $67 |
| Incyte Corporation | 3 | $63 |
| Galderma Laboratories, L.P. | 4 | $63 |
| PFIZER INC. | 2 | $54 |
| Janssen Biotech, Inc. | 3 | $52 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $42 |
| GENZYME CORPORATION | 1 | $33 |
| E.R. Squibb & Sons, L.L.C. | 1 | $26 |
Products named: SKYRIZI, RINVOQ, COSENTYX, Bimzelx, OPZELURA, NEMLUVIO, TREMFYA, ILUMYA.
Industry payments across SC — which companies pay providers there.
